Efficacy of switching from teriparatide to zoledronic acid or denosumab on bone mineral density and biochemical markers of bone turnover in older patients with severe osteoporosis: a real-life study

PURPOSE: Osteoporosis is characterized by loss of bone mass and susceptibility to fracture. Skeletal effects of teriparatide (TPT) are not persistent after drug withdrawal and sequential therapy with bisphosphonates or denosumab (Dmab) after TPT discontinuation represents a valid option. Here, the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dito, Giorgia, Lugaresi, Marina, Degradi, Chiara, Guabello, Gregorio, Longhi, Matteo, Corbetta, Sabrina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462496/
https://www.ncbi.nlm.nih.gov/pubmed/37402061
http://dx.doi.org/10.1007/s12020-023-03431-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462496/
https://www.ncbi.nlm.nih.gov/pubmed/37402061
http://dx.doi.org/10.1007/s12020-023-03431-6

Ejemplares similares